EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes

Camille Bonnet, Anne-Perrine Foray, Eléonore Micoud, Thomas Lafon, Morgane Gossez, Anne-Claire Lukaszewicz, Fabienne Venet, Guillaume Monneret

Annals of Intensive Care · 2026 · 16 · 100007

DOI: 10.1016/j.aicoj.2025.100007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Intensive Care, 2026. Verfasst von Camille Bonnet und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot and CH Lyon-Sud, Lyon France. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Claude Bernard Lyon 1, Hospices Civils de Lyon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Septic shock triggers a complex immune response characterized by the coexistence of hyperinflammation and immunosuppression, the latter being a major driver of ICU-acquired infections and increased mortality. Currently, the most established biomarkers for assessing sepsis-induced immunosuppression rely on flow cytometry-a technique not universally available in clinical practice. In contrast, soluble biomarkers are, in principle, easier to measure. Although assays for soluble PD-L1 (sPD-L1) are not yet standardized, sPD-L1 concentrations may represent a pragmatic alternative, given the putative role of PD-1/PD-L1 signaling in immunosuppressive pathways during sepsis. In this study, we investigated sPD-L1 in relation to established cellular markers of immunosuppression in a cohort of 161 patients with septic shock. sPD-L1 levels were measured using the ELLA microfluidic platform during the first week of ICU admission. We assessed their association with clinical outcomes and explored the relationship between sPD-L1 and immunosuppressive profiles defined by low monocytic HLA-DR expression (mHLA-DR) and absolute lymphocyte count.

Results

Upon admission, patients exhibited elevated sPD-L1 levels compared to healthy controls (medians: 179 vs. 54 pg/mL, p < 0.001). No correlation was observed between sPD-L1 levels and severity scores (SOFA, SAPS II). Elevated sPD-L1 was independently and significantly associated with increased mortality at both 28 and 90 days. Longitudinal analysis using K-means clustering revealed that the cluster with consistently highest sPD-L1 levels was associated with unfavorable outcomes. Overall, and at any single time point, sPD-L1 concentrations did not correlate with mHLA-DR expression or lymphopenia. However, the combined presence of high sPD-L1 and low mHLA-DR levels at the end of the first week identified a subgroup of patients with particularly poor clinical outcomes.

Conclusions

These findings highlight the potential of sPD-L1 as a clinically relevant biomarker in the context of sepsis immunopathology. Further studies are warranted to elucidate its role in the mechanisms underlying sepsis-induced immunosuppression. Such insights could support the integration of sPD-L1 into multimodal biomarker panels for immune monitoring and risk stratification in patients with septic shock.

Schlagwörter

Stichwörter der Autor:innen

BiomarkersHyperinflammationImmunosuppressionSeptic shock

Autor:innen und Institutionen

  • Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot and CH Lyon-Sud, Lyon France.
  • Emergency Department/Inserm CIC 1435, Limoges University Hospital, Limoges, France.
  • NLRP3 Inflammation and Immune Response to Sepsis Team, Centre International de Recherche in Infectiology (CIRI), Inserm U1111, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Claude Bernard University Lyon 1, Lyon Fran…
  • Hospices Civils de Lyon, Anesthesiology and Critical Care Medicine Department, Hôpital E. Herriot, Lyon, France.
  • Université de Lyon, EA 7426 "Pathophysiology of Injury-Induced Immunosuppression", Université Claude Bernard Lyon1, Lyon, France.

Förderung

  • University Claude Bernard Lyon 1
  • Hospices Civils de Lyon

Zitieren

APA

Bonnet, C., Foray, A. P., Micoud, E., Lafon, T., Gossez, M., Lukaszewicz, A. C., Venet, F., & Monneret, G. (2026). Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes. Annals of Intensive Care, 16, 100007. https://doi.org/10.1016/j.aicoj.2025.100007

Vancouver

Bonnet C, Foray AP, Micoud E, Lafon T, Gossez M, Lukaszewicz AC, et al. Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes. Annals of Intensive Care. 2026;16:100007. doi:10.1016/j.aicoj.2025.100007

BibTeX
@article{Bonnet2026,
  author = {Bonnet, Camille and Foray, Anne-Perrine and Micoud, Eléonore and Lafon, Thomas and Gossez, Morgane and Lukaszewicz, Anne-Claire and Venet, Fabienne and Monneret, Guillaume},
  title = {Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes},
  journal = {Annals of Intensive Care},
  year = {2026},
  volume = {16},
  pages = {100007},
  doi = {10.1016/j.aicoj.2025.100007}
}
Kostenlos starten →